News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Rana R. McKay, MD

Advertisement

Articles by Rana R. McKay, MD

Nurses Are "On the Front Lines" for Patients Treated With Radium-223

ByRana R. McKay, MD
February 19th 2020

Nurses are key when it comes to treating patients with prostate cancer who are being given radium-223.

Advertisement

Latest Updated Articles

  • Nurses Are "On the Front Lines" for Patients Treated With Radium-223
    Nurses Are "On the Front Lines" for Patients Treated With Radium-223

    Published: February 19th 2020 | Updated:



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Greenlights Niraparib/Abiraterone Acetate With Prednisone in mHSPC

2

Pembrolizumab Plus RT Ups T-Cell Infiltration in Early Breast Cancer

3

Progression Occurs Early in R/R LBCL Treated With Epcoritamab, Glofitamab

4

Teclistamab/Daratumumab Increases OS, PFS in R/R Multiple Myeloma

5

Oral Azacitidine Yields Similar PK to Subcutaneous Azacitidine in MDS/CMML

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us